Van Berkel; Patricius Hendrikus Cornelis
Patent Applications and Registrations
Patent applications and USPTO patent grants for Van Berkel; Patricius Hendrikus Cornelis.The latest application filed is for "pyrrolobenzodiazepine-antibody conjugates and uses thereof".
Company Profile
18.17.45
- Van Berkel; Patricius Hendrikus Cornelis - Epalinges CH
- VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS - Lausanne CH
- VAN BERKEL; Patricius Hendrikus Cornelis - London GB
Patent Activity
| Patent | Date |
|---|---|
| Pyrrolobenzodiazepine-antibody conjugates Grant 11,384,098 - Van Berkel July 12, 2 | 2022-07-12 |
| Pyrrolobenzodiazepine-antibody Conjugates And Uses Thereof App 20220096654 - van Berkel; Patricius Hendrikus Cornelis ; et al. | 2022-03-31 |
| Humanized Anti-axl Antibodies App 20220073625 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2022-03-10 |
| Anti-il13r Alpha2 Antibodies App 20220033508 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2022-02-03 |
| Combination Therapy With An Anti-cd25 Antibody-drug Conjugate App 20220016259 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2022-01-20 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20220016261 - VAN BERKEL; Patricius Hendrikus Cornelis | 2022-01-20 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20220008552 - VAN BERKEL; Patricius Hendrikus Cornelis | 2022-01-13 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 11,160,872 - Van Berkel November 2, 2 | 2021-11-02 |
| Humanized anti-AXL antibodies Grant 11,059,893 - Van Berkel , et al. July 13, 2 | 2021-07-13 |
| Pyrrolobenzodiazepine-anti-psma Antibody Conjugates App 20210137940 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2021-05-13 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20210113587 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2021-04-22 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20210093731 - VAN BERKEL; Patricius Hendrikus Cornelis | 2021-04-01 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20210079020 - VAN BERKEL; Patricius Hendrikus Cornelis | 2021-03-18 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20200405880 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2020-12-31 |
| Combination Therapy App 20200405879 - Feingold; Jay Marshall ; et al. | 2020-12-31 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20200405873 - FEINGOLD; Jay Marshall ; et al. | 2020-12-31 |
| Site-specific Antibody-drug Conjugates App 20200399365 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2020-12-24 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20200345861 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2020-11-05 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 10,799,596 - Van Berkel , et al. October 13, 2 | 2020-10-13 |
| Pyrrolobenzodiazepine-anti-cd22 Antibody Conjugates App 20200306385 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2020-10-01 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 10,780,181 - Van Berkel , et al. Sept | 2020-09-22 |
| Pyrrolobenzodiazepine--anti-PSMA antibody conjugates Grant 10,751,346 - Van Berkel , et al. A | 2020-08-25 |
| Pyrrolobenzodiazepine-anti-PSMA antibody conjugates Grant 10,736,903 - Van Berkel , et al. A | 2020-08-11 |
| Pyrrolobenzodiazepine-anti-CD22 antibody conjugates Grant 10,722,594 - Howard , et al. | 2020-07-28 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 10,695,433 - Van Berkel , et al. | 2020-06-30 |
| Combination Therapy With An Anti-psma Antibody-drug Conjugate App 20200129638 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2020-04-30 |
| Combination Therapy With An Anti-axl Antibody-drug Conjugate App 20200129637 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2020-04-30 |
| Combination therapy with an anti-axl antibody-drug conjugate Grant 10,544,223 - Van Berkel , et al. Ja | 2020-01-28 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20190358342 - VAN BERKEL; Patricius Hendrikus Cornelis | 2019-11-28 |
| Humanized Anti-axl Antibodies App 20190352407 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2019-11-21 |
| Combination Therapy With An Anti-axl Antibody-drug Conjugate App 20190218291 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2019-07-18 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20190015524 - FEINGOLD; JAY MARSHALL ; et al. | 2019-01-17 |
| Site-specific Antibody-drug Conjugates App 20180303953 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-10-25 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20180250417 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-09-06 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20180193480 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-07-12 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 10,010,624 - Howard , et al. July 3, 2 | 2018-07-03 |
| Pyrrolobenzodiazepine-anti-cd22 Antibody Conjugates App 20180169258 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-06-21 |
| Humanized Anti-axl Antibodies And Their Conjugates App 20180127505 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-05-10 |
| Site-specific Antibody-drug Conjugates App 20180125994 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2018-05-10 |
| Site-specific Antibody-drug Conjugates App 20180117172 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-05-03 |
| Pyrrolobenzodiazepine--antibody conjugates Grant 9,956,299 - Howard , et al. May 1, 2 | 2018-05-01 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 9,950,078 - Howard , et al. April 24, 2 | 2018-04-24 |
| Site-specific Antibody-drug Conjugates App 20180099055 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-04-12 |
| Site-specific Antibody-drug Conjugates App 20180092985 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-04-05 |
| Site-specific Antibody-drug Conjugates App 20180092986 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-04-05 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 9,931,415 - Van Berkel , et al. April 3, 2 | 2018-04-03 |
| Pyrrolobenzodiazepine-antibody conjugates Grant 9,931,414 - Van Berkel , et al. April 3, 2 | 2018-04-03 |
| Site-specific Antibody-drug Conjugates App 20180086828 - VAN BERKEL; PATRICIUS HENDRIKUS CORNELIS ; et al. | 2018-03-29 |
| Pyrrolobenzodiazepine-anti-CD22 antibody conjugates Grant 9,919,056 - Van Berkel , et al. March 20, 2 | 2018-03-20 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20160263239 - Howard; Philip Wilson ; et al. | 2016-09-15 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20160263242 - Howard; Philip Wilson ; et al. | 2016-09-15 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20160256561 - Howard; Philip Wilson ; et al. | 2016-09-08 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20160250346 - Howard; Philip Wilson ; et al. | 2016-09-01 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20150297746 - VAN BERKEL; Patricius Hendrikus Cornelis ; et al. | 2015-10-22 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20150283262 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-10-08 |
| Pyrrolobenzodiazepine-antibody Conjugates App 20150283263 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-10-08 |
| Pyrrolobenzodiazepine - Anti-psma Antibody Conjugates App 20150283258 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-10-08 |
| Pyrrolobenzodiazepine-anti-her2 Antibody Conjugates App 20150273077 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-10-01 |
| Pyrrolobenzodiazepine-anti-psma Antibody Conjugates App 20150273078 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-10-01 |
| Pyrrolobenzodiazepine-anti-cd22 Antibody Conjugates App 20150265722 - Van Berkel; Patricius Hendrikus Cornelis ; et al. | 2015-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 